Femtobiomed Inc.
Non-viral cell engineering platform for rapid, cost-effective cell and gene therapy development.
327610 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 판교로 700D동 510호(야탑동, 분당테크노파크), 성남시
- Website:
- https://www.femtobiomed.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of measuring, testing, navigating and control equipment; watches and clocks
Description
Femtobiomed Inc. is a biotechnology company specializing in non-viral cell engineering and gene delivery technologies for the cell and gene therapy (CAGT) sector. The company's core offering is its CellShot® platform, which employs a patented Partitioned Flow Transfection technology. This system facilitates multiplexed cell engineering through a simplified, bufferless electroporation process. It is designed to overcome challenges in conventional viral-based therapy development by offering significantly reduced production times, lower costs, and high cell viability and yield. The technology supports advanced applications, including mRNA transfection and the creation of multi-target cell therapeutics like CAR-NK, empowering researchers and clinicians to develop next-generation treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-19 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 137.0 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-06-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.5 KB | ||
| 2025-06-13 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.7 KB | ||
| 2025-06-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-09 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 53.3 KB | ||
| 2025-06-09 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 26.7 KB | ||
| 2025-04-28 00:00 |
Capital/Financing Update
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 31.1 KB | ||
| 2025-04-28 00:00 |
Capital/Financing Update
기타주요경영사항(자율공시) (제1회차 전환사채권 발행결정 철회)
|
Korean | 6.4 KB | ||
| 2025-04-02 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.8 KB | ||
| 2025-03-31 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.0 KB | ||
| 2025-03-31 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 108.8 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 19.3 KB | ||
| 2025-03-24 00:00 |
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
|
Korean | 81.6 KB | ||
| 2025-03-20 00:00 |
Share Issue/Capital Change
주요사항보고서(전환사채권발행결정)
|
Korean | 56.8 KB |
Automate Your Workflow. Get a real-time feed of all Femtobiomed Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Femtobiomed Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/GEA_Grenobloise_dElectronique_e_GWnBmN7.jpg)
